AlloVir (ALVR) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
AlloVir, Inc. has been notified by Nasdaq that its stock price fell below the $1.00 minimum bid requirement for 30 days, putting it at risk of delisting. The company remains listed and has 180 days to rectify the situation by maintaining a bid price of $1.00 or more for ten consecutive days. AlloVir is exploring options, including a potential reverse stock split, to regain compliance and avoid delisting from the Nasdaq Global Select Market.
For further insights into ALVR stock, check out TipRanks’ Stock Analysis page.